<H1>Chapter DOI: 10.1007/s00105-015-3716-8<br/>Cited-By Count: 0</H1><table border="1" width="30%"><tr><td>Total References</td><td>40</td></tr><tr><td>Springer references</td><td>4</td></tr><tr><td>Non Springer references</td><td>36</td></tr><tr><td>BibStructured Count</td><td width="10%">35</td></tr><tr><td>BibUnstructured Count</td><td width="10%">5</td></tr><tr><td>DOI already available in SpringerLink</td><td>32</td></tr><tr><td>Additional DOI extracted from CrossRef-Meta</td><td>4</td></tr><tr><td>Additional DOI extracted from CrossRef-Web</td><td>0</td></tr><tr><td>Additional DOI extracted from ResearchGate-Web</td><td>0</td></tr><tr><td>Additional DOI extracted from SpringerLink-FUZZY-Search</td><td>0</td></tr><tr><td>Spelling Mistakes</td><td>NULL</td></tr><tr><td>Wrong DOI</td><td>0</td></tr><tr><td>ISBN</td><td>NULL</td></tr><tr><td>Web Link</td><td>NULL</td></tr><tr><td>DOI Obtained For Springer Published</td><td>0</td></tr><tr><td>DOI Obtained For Non Springer</td><td>4</td></tr><tr><td>DOI Obtained From Structured Ref</td><td>0</td></tr><tr><td>DOI Obtained From Unstructured Ref</td><td>4</td></tr></table></br></br><table border="1">
<tr><th>Bib. ID</th><th>Ref. Type</th><th>References</th><th>DOI</th><th>Suspected DOI</th><th>DOI Source</th><th>Validated Elements</th><th>Validation Source</th></tr><tr><td>CR1</td><td>BibArticle</td><td> Corona G et al (2013) Diagnosis and treatment of late-onset hypogonadism: systematic review and meta-analysis of TRT outcomes. Best Pract Res Clin Endocrinol Metab 27(4):557&#8211;579</td><td><a href=http://dx.doi.org/10.1016/j.beem.2013.05.002>10.1016/j.beem.2013.05.002</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR2</td><td>BibUnstructured</td><td><aug><span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Dean</span> <span style='background:#DDDDDD'>JD</span></span> et al</aug> (<span style='background:#66FF66'>2015</span>) <span style='background:#CCCCFF'>The International Society for Sexual Medicine&#8217;s Process of Care for the Assessment and Management of Testosterone Deficiency in Adult Men</span>. <span style='background:#CCFF99'>J Sex Med</span> <span style='background:#FFCC66'>12</span>(<span style='background:#C8BE84'>8</span>):<span style='background:#D279FF'>1660&#8211;1686</span> doi:<span style='background:#CFBFB1'>10.1111/jsm.12952</span></td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR3</td><td>BibArticle</td><td> Zitzmann M (2009) The role of the CAG repeat androgen receptor polymorphism in andrology. Front Horm Res 37:52&#8211;61</td><td><a href=http://dx.doi.org/10.1159/000175843>10.1159/000175843</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR4</td><td>BibArticle</td><td> Kaufman JM, Vermeulen A (2005) The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocr Rev 26:833&#8211;876</td><td><a href=http://dx.doi.org/10.1210/er.2004-0013>10.1210/er.2004-0013</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR5</td><td>BibArticle</td><td> Rajender S, Singh L, Thangaraj K (2007) Phenotypic heterogeneity of mutations in androgen receptor gene. Asian J Androl 9:147&#8211;179</td><td><a href=http://dx.doi.org/10.1111/j.1745-7262.2007.00250.x>10.1111/j.1745-7262.2007.00250.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR6</td><td>BibBook</td><td> Nieschlag E et al (2009) Andrologie, 3.&nbsp;Aufl. Springer (Verlag), Berlin. (978-3-540-92962-8)</td><td><a href=http://dx.doi.org/10.1007/978-3-540-92963-5>10.1007/978-3-540-92963-5</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR7</td><td>BibBook</td><td> Krause W et al (2011) Andrologie, vierte Auflage. Georg-Thieme-Verlag, Stuttgart. (978-3-13-153224-4)</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR8</td><td>BibUnstructured</td><td><aug><span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Welty</span> <span style='background:#DDDDDD'>FK</span></span></aug> (<span style='background:#66FF66'>2015</span>) <span style='background:#FFD9B3'>Targeting inflammation in metabolic syndrome</span> . Transl Res Jul 3. pii: <span style='background:#D279FF'>S1931-5244(15)00222-4</span></td><td>&nbsp;</td><td><a href=http://dx.doi.org/10.1016/j.trsl.2015.06.017>10.1016/j.trsl.2015.06.017</a></td><td><b>CrossRef-Meta</b></td>
<td>BookTitle, Author_FamilyName_1</td><td>CrossRef</td></tr><tr><td>CR9</td><td>BibArticle</td><td> Saad F, Aversa A, Isidori AM et al (2012) Testosterone as potential effective therapy in treatment of obesity in men with testosterone deficiency: a review. Curr Diabetes Rev 8:131&#8211;143</td><td><a href=http://dx.doi.org/10.2174/157339912799424573>10.2174/157339912799424573</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR10</td><td>BibArticle</td><td> Corona G, Rastrelli G, Vignozzi L et al (2011) Testosterone, cardiovascular disease and the metabolic syndrome. Best Pract Res Clin Endocrinol Metab 5:337&#8211;353</td><td><a href=http://dx.doi.org/10.1016/j.beem.2010.07.002>10.1016/j.beem.2010.07.002</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR11</td><td>BibArticle</td><td> Schuppe HC, Jung A, Ochsendorf FR, K&#246;hn FM (2014) Psoriasis und Partnerschaft Andrologische Aspekte im Auge haben. Hautnah Dermatol 30(2):105&#8211;111</td><td><a href=http://dx.doi.org/10.1007/s15012-014-1747-y>10.1007/s15012-014-1747-y</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR12</td><td>BibArticle</td><td> Costanzo PR, Su&#225;rez SM et al (2014) Evaluation of the hypothalamic-pituitary-gonadal axis in eugonadal men with type 2 diabetes mellitus. Andrology 2:117&#8211;124</td><td><a href=http://dx.doi.org/10.1111/j.2047-2927.2013.00163.x>10.1111/j.2047-2927.2013.00163.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR13</td><td>BibArticle</td><td> Wu FC, Tajar A, Pye SR et al (2008) Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study. J Clin Endocrinol Metab 93:2737&#8211;2745</td><td><a href=http://dx.doi.org/10.1210/jc.2007-1972>10.1210/jc.2007-1972</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR14</td><td>BibArticle</td><td> Dohle GR et al (2013) Leitlinie M&#228;nnlicher Hypogonadismus J. Reproduktionsmed. Endokrinol 10(5&#8211;6):279&#8211;292</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR15</td><td>BibArticle</td><td> Basaria S (2014) Male hypogonadism. Lancet 383(9924):1250&#8211;1263</td><td><a href=http://dx.doi.org/10.1016/S0140-6736(13)61126-5>10.1016/S0140-6736(13)61126-5</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR16</td><td>BibArticle</td><td> Kalyani RR, Dobs AS (2007) Androgen deficiency, diabetes, and the metabolic syndrome in men. Curr Opin Endocrinol Diab Obes 14:226&#8211;234</td><td><a href=http://dx.doi.org/10.1097/MED.0b013e32814db856>10.1097/MED.0b013e32814db856</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR17</td><td>BibArticle</td><td> Boehncke S, Salgo R, Garbaraviciene J, Beschmann H, Ackermann H, Boehncke WH, Ochsendorf FR (2011) Changes in the sex hormone profile of male patients with moderate-to-severe plaque-type psoriasis under systemic therapy: results of a prospective longitudinal pilot study. Arch Dermatol Res 303(6):417&#8211;424</td><td><a href=http://dx.doi.org/10.1007/s00403-011-1157-5>10.1007/s00403-011-1157-5</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR18</td><td>BibArticle</td><td> Wu FC et al (2010) Identification of late-onset hypogonadism in middle-aged and elderly men. N Engl J Med 363:123&#8211;135</td><td><a href=http://dx.doi.org/10.1056/NEJMoa0911101>10.1056/NEJMoa0911101</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR19</td><td>BibUnstructured</td><td><aug><span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Zitzmann</span> <span style='background:#DDDDDD'>M</span></span> et al</aug> (<span style='background:#66FF66'>2006</span>) <span style='background:#CCCCFF'>Association of specific symptoms and metabolic risks with serum testosterone in older men</span>. <span style='background:#CCFF99'>J Clin Endocrinol Metabol</span> <span style='background:#FFCC66'>91</span>:<span style='background:#D279FF'>4335&#8211;4343</span></td><td><a href=http://dx.doi.org/10.1210/jc.2006-0401>10.1210/jc.2006-0401</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>Year, FirstPage, ArticleTitle, VolumeID, Author_FamilyName_1</td><td>CrossRef</td></tr><tr><td>CR20</td><td>BibArticle</td><td> Vermeulen A (2005) Hormonal cut-offs of partial androgen deficiency: a survey of androgen assays. J Endocrinol Invest 28(3 Suppl):28&#8211;31</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR21</td><td>BibArticle</td><td> Rosner W et al (2007) Utility, limitations, and pitfalls in measuring testosterone: an endocrine society position statement. J Clin Endocrinol Metab 92:405&#8211;413</td><td><a href=http://dx.doi.org/10.1210/jc.2006-1864>10.1210/jc.2006-1864</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR22</td><td>BibArticle</td><td> Milenkovi&#263; L, D&#8217;Angelo G, Kelly PA, Weiner RI (1994) Inhibition of gonadotropin hormone-releasing hormone release by prolactin from GT1 neuronal cell lines through prolactin receptors. Proc Natl Acad Sci USA 91:1244&#8211;1247</td><td><a href=http://dx.doi.org/10.1073/pnas.91.4.1244>10.1073/pnas.91.4.1244</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR23</td><td>BibArticle</td><td> Carter JN, Tyson JE, Tolis G, Van Vliet S, Faiman C, Friesen HG (1978) Prolactin-screening tumors and hypogonadism in 22 men. N Engl J Med 299:847&#8211;852</td><td><a href=http://dx.doi.org/10.1056/NEJM197810192991602>10.1056/NEJM197810192991602</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR24</td><td>BibArticle</td><td> Basaria S, Coviello AD et al (2010) Adverse events associated with testosterone administration. N Engl J Med 363:109&#8211;122</td><td><a href=http://dx.doi.org/10.1056/NEJMoa1000485>10.1056/NEJMoa1000485</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR25</td><td>BibArticle</td><td> Srinivas-Shankar U, Roberts SA et al (2010) Effects of testosterone on muscle strength, physical function, body composition, and quality of life in intermediate-frail and frail elderly men: a randomized, double-blind, placebo-controlled study. J Clin Endocrinol Metab 95:639</td><td><a href=http://dx.doi.org/10.1210/jc.2009-1251>10.1210/jc.2009-1251</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR26</td><td>BibArticle</td><td> Saad F, Haider A, Doros G, Traish A (2013) Long-term treatment of hypogonadal men with testosterone produces substantial and sustained weight loss. Obes (Silver Spring) 21:1975&#8211;1981</td><td><a href=http://dx.doi.org/10.1002/oby.20407>10.1002/oby.20407</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR27</td><td>BibArticle</td><td> Muraleedharan V, Marsh H, Kapoor D, Channer KS, Jones TH (2013) Testosterone deficiency is associated with increased risk of mortality and testosterone replacement improves survival in men with type 2 diabetes. Eur J Endocrinol 169:725&#8211;733</td><td><a href=http://dx.doi.org/10.1530/EJE-13-0321>10.1530/EJE-13-0321</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR28</td><td>BibArticle</td><td> Camacho EM, Huhtaniemi IT, O&#8217;Neill TW et al (2013) Age associated changes in hypothalamic pituitary testicular function in middle aged and older men are modified by weight change and lifestyle factors: longitudinal results from the European Male Ageing Study. Eur J Endocrinol 168:445&#8211;455</td><td><a href=http://dx.doi.org/10.1530/EJE-12-0890>10.1530/EJE-12-0890</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR29</td><td>BibUnstructured</td><td><aug><span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Corona</span> <span style='background:#DDDDDD'>G</span></span> et al</aug> (<span style='background:#66FF66'>2015</span>) <span style='background:#FFD9B3'>Obesity and late-onset hypogonadism</span> . Mol Cell Endocrinol Jul 2. pii: <span style='background:#D279FF'>S0303-7207(15)00338-X</span></td><td><a href=http://dx.doi.org/10.1016/j.mce.2015.06.031>10.1016/j.mce.2015.06.031</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>Year, Author_FamilyName_1, BookTitle</td><td>CrossRef</td></tr><tr><td>CR30</td><td>BibUnstructured</td><td><aug><span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Vignozzi</span> <span style='background:#DDDDDD'>L</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Filippi</span> <span style='background:#DDDDDD'>S</span></span> et al</aug> (<span style='background:#66FF66'>2014b</span>) <span style='background:#CCCCFF'>Metformin in vitro and in vivo increases adenosine signaling in rabbit corpora cavernosa</span>. <span style='background:#CCFF99'>J Sex Med</span> <span style='background:#FFCC66'>11</span>:<span style='background:#D279FF'>1694&#8211;1708</span></td><td><a href=http://dx.doi.org/10.1111/jsm.12572>10.1111/jsm.12572</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>Author_FamilyName_2, Author_FamilyName_1, FirstPage, VolumeID, ArticleTitle, Year</td><td>CrossRef</td></tr><tr><td>CR31</td><td>BibArticle</td><td> Schreiber G et al (2008) The aging male-diagnosis and therapy of late-onset hypogonadism. J Dtsch Dermatol Ges 6(4):273&#8211;279</td><td><a href=http://dx.doi.org/10.1111/j.1610-0387.2008.06493.x>10.1111/j.1610-0387.2008.06493.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR32</td><td>BibArticle</td><td> Medras M, Filus A, Jozkow P et al (2006) Breast cancer and long term hormonal treatment of male hypogonadism. Breast Cancer Res Treat 96:263&#8211;265</td><td><a href=http://dx.doi.org/10.1007/s10549-005-9074-y>10.1007/s10549-005-9074-y</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR33</td><td>BibArticle</td><td> Seftel AD et al (2015) Critical update of the 2010 endocrine society clinical practice guidelines for male hypogonadism: a systematic analysis. Mayo Clin Proc 90(8):1104&#8211;1115</td><td><a href=http://dx.doi.org/10.1016/j.mayocp.2015.06.002>10.1016/j.mayocp.2015.06.002</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR34</td><td>BibArticle</td><td> Klap J et al (2015) The relationship between total testosterone levels and prostate cancer: a review of the continuing controversy. J Urol 93(2):403&#8211;413</td><td><a href=http://dx.doi.org/10.1016/j.juro.2014.07.123>10.1016/j.juro.2014.07.123</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR35</td><td>BibArticle</td><td> Morgentaler A, Morales A (2010) Should hypogonadal men with prostate cancer receive testosterone? J Urol 184:1257&#8211;1260</td><td><a href=http://dx.doi.org/10.1016/j.juro.2010.07.010>10.1016/j.juro.2010.07.010</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR36</td><td>BibArticle</td><td> Kaufman JM, Graydon RJ (2004) Androgen replacement after curative radical prostatectomy for prostate cancer in hypogonadal men. J Urol 172:920&#8211;922</td><td><a href=http://dx.doi.org/10.1097/01.ju.0000136269.10161.32>10.1097/01.ju.0000136269.10161.32</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR37</td><td>BibArticle</td><td> Corona G, Maseroli E et al (2014) Cardiovascular risk associated with testosterone-boosting medications: a systematic review and meta-analysis. Expert Opin Drug Saf 13:1327&#8211;1351</td><td><a href=http://dx.doi.org/10.1517/14740338.2014.950653>10.1517/14740338.2014.950653</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR38</td><td>BibArticle</td><td> Jones SD Jr (2015) Thomas Dukovac Erythrocytosis Secondary to TRT. Sex Med Rev 3:101&#8211;112</td><td><a href=http://dx.doi.org/10.1002/smrj.43>10.1002/smrj.43</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR39</td><td>BibArticle</td><td> Hanafy HM (2007) Testosterone therapy and obstructive sleep apnea: is there a real connection? J Sex Med 4:1241&#8211;1246</td><td><a href=http://dx.doi.org/10.1111/j.1743-6109.2007.00553.x>10.1111/j.1743-6109.2007.00553.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR40</td><td>BibArticle</td><td> Hoyos CM, Yee BJ et al (2012) Body compositional and cardiometabolic effects of testosterone therapy in obese men with severe obstructive sleep apnoea: a randomised placebo-controlled trial. Eur J Endocrinol 167(4):531&#8211;541</td><td><a href=http://dx.doi.org/10.1530/EJE-12-0525>10.1530/EJE-12-0525</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr></table>